Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wightman

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Substance Abuse Treatment|March 27, 2021
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode IslandSeth A Clark, Corey Davis, Rachel S Wightman, et al.
Rhode Island Medical Journal (2013)|September 27, 2024
Statewide Ketamine and Esketamine Prescribing Trends in Rhode Island, 2017-2023Taylor J Paiva, Benjamin D Hallowell, Staci Fischer, et al.
Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|June 17, 2014
Abstracts of the 2014 AWHONN Annual Convention, June 14-18, 2014, Orlando, FloridaTonia Russell, Astrid S Wightman, Chris Cannon, et al.
Substance Use & Misuse|November 17, 2025
Enhancing Harm Reduction Through Drug Checking and Community Outreach: Feedback from People Who Use Drugs on Drug Supply Safety, Dissemination of Information, and Service NeedsAmy J Arthur, Alexandra B Collins, E Claire Macon, et al.
BMJ Open|November 9, 2024
Randomised clinical trial of a 16 mg vs 24 mg maintenance daily dose of buprenorphine to increase retention in treatment among people with an opioid use disorder in Rhode Island: study protocol paperKelsey Armeni, Laura C Chambers, Alyssa Peachey, et al.
The Journal of Clinical Psychiatry|July 18, 2006
Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studiesAnita H Clayton, Harry A Croft, Joseph P Horrigan, et al.
Annals of Emergency Medicine|July 21, 2023
Cannabis Use Patterns and Whole-Blood Cannabinoid Profiles of Emergency Department Patients With Suspected Cannabinoid Hyperemesis SyndromeRachel S Wightman, Jane Metrik, Timmy R Lin, et al.
The American Journal of Emergency Medicine|September 4, 2021
Tele-buprenorphine for emergency department overdose visit follow up and treatment initiationRachel S Wightman, Brendan Jacka, Julia Uber, et al.
Rhode Island Medical Journal (2013)|September 28, 2023
Multiple Hospital In-Situ Mass Casualty Incident Training Simulation for Emergency Medicine Residents: A Sarin Bomb ScenarioNicholas J Musisca, Heather Rybasack-Smith, Andrew Musits, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 24, 2002
Efficacy and safety of fluticasone propionate 250 microg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroidsWilliam E Berger, Linda B Ford, Todd Mahr, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Substance Abuse Treatment|March 27, 2021
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode IslandSeth A Clark, Corey Davis, Rachel S Wightman, et al.
Rhode Island Medical Journal (2013)|September 27, 2024
Statewide Ketamine and Esketamine Prescribing Trends in Rhode Island, 2017-2023Taylor J Paiva, Benjamin D Hallowell, Staci Fischer, et al.
Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|June 17, 2014
Abstracts of the 2014 AWHONN Annual Convention, June 14-18, 2014, Orlando, FloridaTonia Russell, Astrid S Wightman, Chris Cannon, et al.
Substance Use & Misuse|November 17, 2025
Enhancing Harm Reduction Through Drug Checking and Community Outreach: Feedback from People Who Use Drugs on Drug Supply Safety, Dissemination of Information, and Service NeedsAmy J Arthur, Alexandra B Collins, E Claire Macon, et al.
BMJ Open|November 9, 2024
Randomised clinical trial of a 16 mg vs 24 mg maintenance daily dose of buprenorphine to increase retention in treatment among people with an opioid use disorder in Rhode Island: study protocol paperKelsey Armeni, Laura C Chambers, Alyssa Peachey, et al.
The Journal of Clinical Psychiatry|July 18, 2006
Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studiesAnita H Clayton, Harry A Croft, Joseph P Horrigan, et al.
Annals of Emergency Medicine|July 21, 2023
Cannabis Use Patterns and Whole-Blood Cannabinoid Profiles of Emergency Department Patients With Suspected Cannabinoid Hyperemesis SyndromeRachel S Wightman, Jane Metrik, Timmy R Lin, et al.
The American Journal of Emergency Medicine|September 4, 2021
Tele-buprenorphine for emergency department overdose visit follow up and treatment initiationRachel S Wightman, Brendan Jacka, Julia Uber, et al.
Rhode Island Medical Journal (2013)|September 28, 2023
Multiple Hospital In-Situ Mass Casualty Incident Training Simulation for Emergency Medicine Residents: A Sarin Bomb ScenarioNicholas J Musisca, Heather Rybasack-Smith, Andrew Musits, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 24, 2002
Efficacy and safety of fluticasone propionate 250 microg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroidsWilliam E Berger, Linda B Ford, Todd Mahr, et al.
Pageof 7